tradingkey.logo

KeifeRX Announces Research Collaboration & Option Agreement With Amneal Pharmaceuticals

ReutersJan 9, 2026 4:04 PM

- KeifeRX:

  • KEIFERX ANNOUNCES RESEARCH COLLABORATION AND OPTION AGREEMENT WITH AMNEAL PHARMACEUTICALS TO ADVANCE KFRX06, A BRAIN-PENETRANT LRRK2 PROGRAM FOR PARKINSON’S DISEASE

  • KEIFERX: FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI